138 related articles for article (PubMed ID: 11306921)
1. The role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of Th2 cell differentiation.
Nakayama T; Yamashita M; Kawano T; Shimizu C; Shibata Y; Kamata T; Kaneko Y; Kobayashi S; Takeda U; Motohashi S; Cui J; Taniguchi M
Int Arch Allergy Immunol; 2001; 124(1-3):38-42. PubMed ID: 11306921
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of T helper cell type 2 cell differentiation and immunoglobulin E response by ligand-activated Valpha14 natural killer T cells.
Cui J; Watanabe N; Kawano T; Yamashita M; Kamata T; Shimizu C; Kimura M; Shimizu E; Koike J; Koseki H; Tanaka Y; Taniguchi M; Nakayama T
J Exp Med; 1999 Sep; 190(6):783-92. PubMed ID: 10499917
[TBL] [Abstract][Full Text] [Related]
3. Role of alpha-galactosylceramide-activated Valpha14 natural killer T cells in the regulation of allergic diseases.
Iwamura C; Nakayama T
Allergol Int; 2007 Mar; 56(1):1-6. PubMed ID: 17259803
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways.
Hayakawa Y; Takeda K; Yagita H; Van Kaer L; Saiki I; Okumura K
J Immunol; 2001 May; 166(10):6012-8. PubMed ID: 11342617
[TBL] [Abstract][Full Text] [Related]
5. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
[TBL] [Abstract][Full Text] [Related]
6. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
[TBL] [Abstract][Full Text] [Related]
7. Essential role of LFA-1 in activating Th2-like responses by alpha-galactosylceramide-activated NKT cells.
Matsumoto G; Kubota E; Omi Y; Lee U; Penninger JM
J Immunol; 2004 Oct; 173(8):4976-84. PubMed ID: 15470040
[TBL] [Abstract][Full Text] [Related]
8. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A
Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
[TBL] [Abstract][Full Text] [Related]
9. IL-18 time-dependently modulates Th1/Th2 cytokine production by ligand-activated NKT cells.
Uchida T; Kinoshita M; Fukasawa M; Habu Y; Shinomiya N; Seki S
Eur J Immunol; 2007 Apr; 37(4):966-77. PubMed ID: 17330820
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
[TBL] [Abstract][Full Text] [Related]
11. The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells.
Kitamura H; Iwakabe K; Yahata T; Nishimura S; Ohta A; Ohmi Y; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nishimura T
J Exp Med; 1999 Apr; 189(7):1121-8. PubMed ID: 10190903
[TBL] [Abstract][Full Text] [Related]
12. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
[TBL] [Abstract][Full Text] [Related]
13. IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: a pro-Th2 effect of IL-18 exerted through NKT cells.
Leite-De-Moraes MC; Hameg A; Pacilio M; Koezuka Y; Taniguchi M; Van Kaer L; Schneider E; Dy M; Herbelin A
J Immunol; 2001 Jan; 166(2):945-51. PubMed ID: 11145671
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of the invariant Valpha14 antigen receptor in NKT cells upon activation.
Harada M; Seino K; Wakao H; Sakata S; Ishizuka Y; Ito T; Kojo S; Nakayama T; Taniguchi M
Int Immunol; 2004 Feb; 16(2):241-7. PubMed ID: 14734609
[TBL] [Abstract][Full Text] [Related]
15. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
Maeda M; Yanagawa Y; Iwabuchi K; Minami K; Nakamaru Y; Takagi D; Fukuda S; Onoé K
Immunobiology; 2007; 212(7):537-47. PubMed ID: 17678711
[TBL] [Abstract][Full Text] [Related]
16. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells.
Miyamoto K; Miyake S; Yamamura T
Nature; 2001 Oct; 413(6855):531-4. PubMed ID: 11586362
[TBL] [Abstract][Full Text] [Related]
17. alpha-Galactosylceramide, a ligand of natural killer T cells, inhibits allergic airway inflammation.
Matsuda H; Suda T; Sato J; Nagata T; Koide Y; Chida K; Nakamura H
Am J Respir Cell Mol Biol; 2005 Jul; 33(1):22-31. PubMed ID: 15802553
[TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.
Iizuka A; Ikarashi Y; Yoshida M; Heike Y; Takeda K; Quinn G; Wakasugi H; Kitagawa M; Takaue Y
Immunology; 2008 Jan; 123(1):100-7. PubMed ID: 18005033
[TBL] [Abstract][Full Text] [Related]
19. Freshly isolated Valpha24+ CD4+ invariant natural killer T cells activated by alpha-galactosylceramide-pulsed B cells promote both IgG and IgE production.
Rossignol A; Barra A; Herbelin A; Preud'homme JL; Gombert JM
Clin Exp Immunol; 2007 Jun; 148(3):555-63. PubMed ID: 17362268
[TBL] [Abstract][Full Text] [Related]
20. The regulatory role of Valpha14 NKT cells in innate and acquired immune response.
Taniguchi M; Harada M; Kojo S; Nakayama T; Wakao H
Annu Rev Immunol; 2003; 21():483-513. PubMed ID: 12543936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
